Acute Myocardial Infarction Ami clinical trials

Explore recruiting acute myocardial infarction ami clinical trials.

Recruiting acute myocardial infarction ami studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Myocardial Infarction Ami trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

Austria, Netherlands, Denmark, Poland, Romania, Slovakia +17 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An investigator-initiated, multicenter, open-label, parallel arm, active comparator, randomized study to compare the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with left ventricular thrombus after acute myocardial infarction.

Sweden, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effects of ziltivekimab versus placebo on coronary atherosclerosis in patients with acute myocardial infarction. A serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study

Italy, Netherlands, Austria, Denmark, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

LOW-DOSE DOBUTAMINE INFUSION AND SINGLE-DOSE TOCILIZUMAB IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH RISK OF CARDIOGENIC SHOCK DEVELOPMENT (DOBERMANN) - A 2X2 MULTIFACTORIAL, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Acute Myocardial Infarction Ami trials by city

Acute Myocardial Infarction Ami clinical trials

Recruiting acute myocardial infarction ami studies right now

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

Arrhythmia Detection After MI

Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction

Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Ivabradine in the Acute Management of Cardiogenic Shock

Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO

Also recruiting in Europe

An investigator-initiated, multicenter, open-label, parallel arm, active comparator, randomized study to compare the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with left ventricular thrombus after acute myocardial infarction.

Effects of ziltivekimab versus placebo on coronary atherosclerosis in patients with acute myocardial infarction. A serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study

LOW-DOSE DOBUTAMINE INFUSION AND SINGLE-DOSE TOCILIZUMAB IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH RISK OF CARDIOGENIC SHOCK DEVELOPMENT (DOBERMANN) - A 2X2 MULTIFACTORIAL, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Acute Myocardial Infarction Ami trials by city

Other conditions